After surging 400% yesterday, Aethlon Medical, Inc. AEMD shares are trading lower after the company announced a 1.38-million share registered direct offering priced at $9 per share.
The gross proceeds to Aethlon, before deducting placement agent fees and other offering expenses, are expected to be approximately $12.425 million.
Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense.
Aethlon Medical's stock was trading 29.4% lower at $7.62 on Thursday at the time of publication. The stock has a 52-week high of $12.49 and a 52-week low of $1.22.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
